Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical application.
Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical application.
复制标题
DOI:
10.1016/j.esmoop.2022.100400
复制
发表时间:
2022-04
期刊:
影响因子:
7.3
通讯作者:
Kather, J. N.
中科院分区:
文献类型:
--
作者:
Echle, A.;Laleh, N. Ghaffari;Quirke, P.;Grabsch, H., I;Muti, H. S.;Saldanha, O. L.;Brockmoeller, S. F.;van den Brandt, P. A.;Hutchins, G. G. A.;Richman, S. D.;Horisberger, K.;Galata, C.;Ebert, M. P.;Eckardt, M.;Boutros, M.;Horst, D.;Reissfelder, C.;Alwers, E.;Brinker, T. J.;Langer, R.;Jenniskens, J. C. A.;Offermans, K.;Mueller, W.;Gray, R.;Gruber, S. B.;Greenson, J. K.;Rennert, G.;Bonner, J. D.;Schmolze, D.;Chang-Claude, J.;Brenner, H.;Trautwein, C.;Boor, P.;Jaeger, D.;Gaisa, N. T.;Hoffmeister, M.;West, N. P.;Kather, J. N.
关键词:
Microsatellite instability (MSI)/mismatch repair deficiency (dMMR) is a key genetic feature which should be tested in every patient with colorectal cancer (CRC) according to medical guidelines. Artificial intelligence (AI) methods can detect MSI/dMMR directly in routine pathology slides, but the test performance has not been systematically investigated with predefined test thresholds. We trained and validated AI-based MSI/dMMR detectors and evaluated predefined performance metrics using nine patient cohorts of 8343 patients across different countries and ethnicities. Classifiers achieved clinical-grade performance, yielding an area under the receiver operating curve (AUROC) of up to 0.96 without using any manual annotations. Subsequently, we show that the AI system can be applied as a rule-out test: by using cohort-specific thresholds, on average 52.73% of tumors in each surgical cohort [total number of MSI/dMMR = 1020, microsatellite stable (MSS)/ proficient mismatch repair (pMMR) = 7323 patients] could be identified as MSS/pMMR with a fixed sensitivity at 95%. In an additional cohort of N = 1530 (MSI/dMMR = 211, MSS/pMMR = 1319) endoscopy biopsy samples, the system achieved an AUROC of 0.89, and the cohort-specific threshold ruled out 44.12% of tumors with a fixed sensitivity at 95%. As a more robust alternative to cohort-specific thresholds, we showed that with a fixed threshold of 0.25 for all the cohorts, we can rule-out 25.51% in surgical specimens and 6.10% in biopsies. When applied in a clinical setting, this means that the AI system can rule out MSI/dMMR in a quarter (with global thresholds) or half of all CRC patients (with local fine-tuning), thereby reducing cost and turnaround time for molecular profiling. We describe the largest multicentric study of AI in molecular cancer diagnostics to date. Our open-source AI system achieves a high pre-screening performance for detection of MSI. Our data highlight the role of large-scale validation of AI biomarkers in different geographic and ethnic populations.
登录
查看更多内容
影响因子:
29.4
作者:
Boland CR;Goel A
通讯作者:
Goel A
影响因子:
11.5
作者:
Grabsch, H;Dattani, M;Mueller, W
通讯作者:
Mueller, W
影响因子:
2.7
作者:
Lee, Hyunseok;Seo, Jihyun;Hong, Ayoung
通讯作者:
Hong, Ayoung
影响因子:
168.9
作者:
Gray, Richard;Barnwell, Jennifer;Kerr, David J.
通讯作者:
Kerr, David J.
影响因子:
22.7
作者:
Kather JN;Heij LR;Grabsch HI;Loeffler C;Echle A;Muti HS;Krause J;Niehues JM;Sommer KA;Bankhead P;Kooreman LF;Schulte JJ;Cipriani NA;Buelow RD;Boor P;Ortiz-Brüchle NN;Hanby AM;Speirs V;Kochanny S;Patnaik A;Srisuwananukorn A;Brenner H;Hoffmeister M;van den Brandt PA;Jäger D;Trautwein C;Pearson AT;Luedde T
通讯作者:
Luedde T